REFERENCES
1. Kat zaeava Z, Jensen R. Medication-overuse lieudache: Where
are we now? Cuur open Nemol 2007; 20: 326-30.
2. Rossi P, DI Lorenzo C, Faroni J, Cesarino F, Bappi G.
Advice alone Vs. Structured detoxification programmesdor medication overuse
headhace: a prospective, randomized, open-label trial in transformed migraine
patients with low medical needs. Cephalagie 2006; 26: 1097-1105
3. Katsarava Z, Sch nee weiss S, Kurth T. et AL. incidence and
predictor for Chronicity of headhace in patients with epsodie migraine.
Nemology 2004; 62 (5): 788-790 15 a Lipton RB. Tracing transformation: chronic
migration classification, progression, and epidemology.Nemology 2009; 72 (5
suppl): 53-87
4. Mathew NT. Tension-type Leadache.CurrNemolNeuroshi Rep
2006; 6 (2): 100-105.
5. Rossi, Faromi J., tassorelli C, Nappi G. Diagnostic delay
and suboptimal management in a refebal population with hemicinia continua.
Headache 2009; 49 (2): 227-234.
6. Russell MB, Levi N, Saltyte-Benth j Epidemiol 2006:
classification and phagnosis. Curr pain Headache rep 2005. 9 (6)/ 423-429.
7. Bigal MF, Lipton RB. Tension -type headache: classification
and diagnosis. Curr pain Headache Rep 2005. 9 (6): 423.429.
8. Ferrari A, Leone 5, Veragoni AV, Bertolini A, Sances G.
Coccia CPR et al Similanties and differences LetweenChronci migraine and
episodic migraine. headache 2007, 47: 65-72.
9. Schwedt TJ, Dodick DW. advencedneuro, maging of migraine
Lancet Neurol 2009; 8 (6): 560-568.
10. Evans R, Purdy A (2006) Identification or exclusion of
secondary headache in: Lipton RB ,Bigal ME (eds) Migraine and other
heaachedisordes. Informal healthcare, New York, Pp 131-144;
11. KruntMc, Lanneoverbosh J, VAN Buchen MA, Ferrari MD. Iron
accumulation in deep brain migraine: a population based magnetic resonnace
imaging a population based magnetic resonance imaging study. Cephalalgia 2009,
29: 351-359.
12. Silberstein SD, Schwedt TJ. 14th International Headache
Congress in phaldesphia. Headache .2010 Mar; 50 (3): 509-19.
13. International Headache Society. Ntezrnational
Classification of Headache Disordey; 2nd ed. Cephalalgie 2006; 24 (suppl 1):
9-160.
14. Scher AL, Stewart WF, Buse D, Krantz DS, Lipton RB. Major
Life changes before and after the ouset of chronic daily headache: a population
- based study. Cephalagie 2008; 28 (8): 868-876.
15. Sancisi e, Cevoli S, Pierangeli G et al (2007),
Appliction of ICHAD-II and revised diagnosticecutenia to atients with chronic
daily headac he.Neurol SCI 28/ 2-8.
16. NataliWiendel J et al. Maux de tête chronique
fréquenter dans la population
générale.LeidenUniversityMedical Center, Feb 2008: 978-90-90227
33-7.
17. Wiendels NJ, Ferreri MD, Assendelft WJJ. Cephalis
Chroniques Fréquentes: prévalence et Facteurs associés.
Céphalées, 2006 ; 26 (12) : 1434 -42.
18. Wiendels NJ et al. Céphalées chroniques
quotidiennes : prévalence et HIT (Headache, 2007 ; 47 ;
7-12).
19. Bigal ME, Rapoport AM, Tepper SJ et al (2005) The
classification of chronic daily headache in dults -a comparision between the
second edition of the international classification of headache disordes and
alternative diagnostic criteria. Heda 45: 582-589.
20. Sheftelle FD, Bigal ME (2006) Medica tion overuse head
ache Cont, micin 12: 147-163
21. Munakata S, Haz ard E, Serra no D. et al Economic Buerder
of transformed migraine: resuets from the AnecarMigaine. Prevalance and
prevention (AMPP) Study.Headache 2009. 49 (4): 498-508.
22. World Health organsiation. Mars 2004, n° 277
information.
23. Dodick DW. Clinical practiler ;Chronci daily
headache. N Engl J. red 2006, 354: 158-165.
24. Schmitz N, ADMIRAAL - Betloul, Arkink EB. ET AL. Attack
frequency and disease duration as indicators for Brain damage in migraine.
Headache 2008; 48 (7): 1044-1055.
25. Valfie W, Rainero I, Bergin M, Pinessi L. Voxel -bard
morphonety reveals gray matter abnormalities in migraine. Heaache 2008; 48 (1):
109-117.
26. 27. Rocla MA, Ceccarelli A, Falini A. et AL. Brain gray
matter changes in migraine patients with T2 - visible lessons: a 3-T Mri
STUDY. Strake 2006 ; 37 (7) : 1765 -1770.
27. Schmit Z N, ArkinKeb, Mulder M.et al. Frontal lobe
structure and executive function in migraine patients.Neuroshilett 2008; 440:
92-96.
28. Granziena C, Dasilua AF, Snyder J. Tuch DS , Hadjikhani N.
Anatomical alteration of the visual motion processing network in migraine and
without aura plos red 2006; 3 (10): 2 402.
29. Ash Kenazi A, Mushtaq A, yang I, oshinsky ML lotal and
interictalphonophobia in migraine - a quantitative entrolled study. Cephalagia
2009; 29 (10): 1042-1048.
30. Silberstein SD, Lipton RB, Do dick DW. TOPIRAMATE CHRONIC
MIGRAINE STUDY GROUP ET AL Efficacy and safety of topiramate for true treatment
of chronci migraine: a randimized, double-blind, placebo-controlled trial.
Headache 2007; 47 (2): 170-180.
31. Drener HC, Bussone G, van oene JC, la Haye M, Schwzlens,
GoadsbyPj. To Pmat-MIG-201 (Top-chrome) study group. Tpoiramate reduces
headache daus in chronic migraine; a randomized, double-blind,
placeto-controlled study. Cephalagia 2007; 27 (7); 814-823.
32. Rapport AM, Sheftell FD, Tepper SJ, Bigal M. levebiracetan
in the preventive treatment of transformed maigraine- Curr the res 2005, 66:
212-221.
33. Naumann M, 80 Y, Argoff CE. Thrapeutics and technology
assessment subcommittee of the American Academy of neurology et al assessment:
Botulimu Memotoxin in the treatment of autono,icdisordey and pain (an
evidence-based revieuw): report of the therapeutics and technology assessement
subcommittee of the American of Neurology. Neurology 2008; 70
(19).1707-1714.
34. Spengos ,Thelenes C. paparrigopoulon T. preventive and
NMDA antagonism for chronic mmigraine: A potentially novel therapeutic
approach? Headache 2008; 48 (2): 284-286.
35. Bigal M, Rapoprt A, Sheftell F, Tepper D, Tepper S.
Mementine in the preventive treatment of refractory migraine Headache 2008, 48:
1337-1342.
36. Slock JL, Cho Hl? Chung CS. From transformed migraine to
episodic migraine: reversion faction. Headache 2006; 46 (7): 1186-1190.
37. Garzal, SwaasonJw: Prophylaxiq of migraine.
NeuropsychatrDir Treat 2006; 2 (3): 281-291.
38. Jensen R, Becker WJ- Symptomatology of chronic
tension-type headache. In :glesen J. Ramadan NM, Tfelt Hansen p. Weltch KMA the
Headaches. 3rd ed. Phiadelphia; hippicott Williams and Wilkins 2006:
693-699.
39. Bendtsen L, Jensen R. Tension-type headache: the most
Common? But also the most nelected, headache disorder.CurropinNeurol 2006; 19
(3): 305-309.
40. Fumal AS. Chronic tension-type headache in: Goadsby PJ,
DodickDw Chronic Daily Headache for clinicians 1st ed. Hamilton, Ontario, BC
Decker inc. 2005; 57-64.
41. Crancarelli, Tozzi-Crabcarelli MG, SPACCA g? di Massimo C,
Carolli a. Relation ship between brafeed back and oxidative stress I patients
with chronic migraine. Cephalalgie 2007; 27 (10): 1136-1141.
42. Martion PR, for sylt MRI, Recce J. cognotive-behavioral
therapy versus temporel pulse amplitude brofeed back training for recurrent
headache. Behavther 2007; 38 (4): 350-363.
43. Boes CJ, Black DF, DODOCK Dw. Pathophysiology and
management of transformed migraine and medicatum overuse headache. SeminNeurol
2006; 26 (2): 232-241.
44. MarmuraMj. Silberstein SD, Cupta M. hemiciania .......:
who reponds to indonethacin? Cephalagia 2009; 29 (3): 300.
45. Rozen TD. Relatononresonsivehemiciania .......... Heaache
2006; 46 (7): 1203-1204.
| 
